The European mass spectrometry market, mainly driven by technological advancements, increased pharmaceutical research, growing concern for food safety, and increase in investments, funds and grants by government bodies worldwide, was valued at $1229.2 million in 2013, and expected to reach $1810.5 million by 2018, at a CAGR of 8.1%.
The report ‘European Mass Spectrometry Market forecast, 2012-2018’ analyzes the market by segments on the basis of technologies, such as tandem LC/MS, LC/MS-TOF, MALDI-TOF, single quadrupole, Fourier transform, and gas chromatography. The mass spectrometry market is predominantly driven by the tandem LC/MS technology, followed by gas chromatography, and LC/MS-TOF. With a market value of $516.2 million and $184.4 million, tandem LC/MS and gas chromatography segments have been contributing 42% and 15% respectively in terms of the total internal beam radiotherapy devices market.
The highest share of tandem LC/MS is attributed to the increasing awareness regarding preventive health and safety, leading to an increase in the list of regulated compounds and analytes, as well as the demand for high-throughput analysis pharmaceutical companies.
North America dominated the mass spectrometry market, followed by Europe and Asia. Europe is an established market for mass spectrometry, and is currently witnessing steady growth mainly due to the strict regulations for food and drug safety and the strong research base in the region. Germany commanded the largest share of the European mass spectrometry market.
The research-based pharmaceutical industry can play a critical role in restoring Europe to its growth post the economic slow-down and in ensuring future competitiveness in an advancing global economy. In 2012, it invested an estimated €30,000 million in R&D in Europe.
Research environment in emerging economies, such as Brazil, China, and India has led to a gradual migration of economic and research activities from Europe to these fast-growing markets. In 2012, the Brazilian and Chinese markets grew by 16% and 21% respectively, compared to an average market growth of minus 2% for the five major European markets and minus 1% for the U.S. market.
The United States has the largest number of biotechnology firms with 6213 firms in the region, followed by France with 1359 firms, and Spain 1095 with firms. The 18 reporting countries from the European Union have a total of 5,398 firms.
According to World Health Organization, The global pharmaceuticals market is worth $300 billion a year, a figure that is expected to rise to $400 billion within three years. The 10 largest drugs companies in this sector have control over one-third of this market, several with the sales of more than $10 billion a year and profit margins of about 30%. Six are based in the United States and four in Europe. It is predicted that North and South America, Europe, and Japan will continue to account for a full 85% of the global pharmaceuticals market well into the 21st century.
The report also provides an extensive competitive landscaping of companies operating in this market. The major companies in this market are Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), PerkinElmer (U.S.), Thermofisher Scientific (U.S.), Bruker (U.S), Rigaku (Japan), Waters Corporation (U.S), Danaher Corporation (U.S.), and Shimadzu Corporation (Japan).
Segment and country-specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed.
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Procedure Volume Data
- Number of spectroscopy instruments installed
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
- The company share analysis of the mass spectrometry market in the region
- The crucial developments and strategies of companies inculcated in their portfolio
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Mass spectrometry-Europe, by Technologies
4.1 Tandem LC-MS-Europe
4.3 LC/MS TOF-Europe
4.4 MALDI TOF-Europe
4.5 Single Quadrupole-Europe
4.6 Fourier transform-Europe
4.7 Other MS-Europe
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement